Oxidized low-density lipoprotein and adiponectin levels in pregnancy

Gynecological Endocrinology

Volumn 27, Issue 12, 2011, Pages 1070-1073

  Makedou, Kali ^a   Kourtis, Anargyros ^a   Gkiomisi, Athina ^b   Toulis, Konstantinos A ^b   Mouzaki, Maria ^a   Anastasilakis, Athanasios D ^b   Gerou, Spyridon ^c   Gavana, Elpida ^c   Agorastos, Theodoros ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b 424 General Army Hospital   (Greece)

^c Laboratories Analysis   (Greece)

Author keywords

adiponectin; insulin resistance; lipids; Oxidized LDL; pregnancy

Indexed keywords

ADIPONECTIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HYPERLIPIDEMIA; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; NORMAL HUMAN; OXIDATION; OXIDATIVE STRESS; PREGNANCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPONECTIN; ADULT; ATHEROSCLEROSIS; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; INSULIN RESISTANCE; LIPOPROTEINS, LDL; OXIDATIVE STRESS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; RISK FACTORS; TRIGLYCERIDES; YOUNG ADULT;

EID: 79961224964     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2011.569793     Document Type: Article

References (29)

1. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006;29(Suppl 1):S43-S48.
2. Gestational Diabetes Mellitus. American Diabetes Association. Diabetes Care 2003;(Suppl 1):S103-S105.
3. Hadden DR. Geographic, ethnic, and racial variations in the incidence of gestational diabetes mellitus. Diabetes 1985;34 (Suppl 2):8-12.
4. Abrams B, Parker J. Overweight and pregnancy complications. Int J Obes 1988;12(4):293-303.
5. Jarvie E, Hauguel-de-Mouzon S, Nelson SM, Sattar N, Catalano PM, Freeman DJ. Lipotoxicity in pregnant women and its potential role in adverse pregnancy outcome and obesity in the offspring. Clin Sci 2010;119:123-129.
6. Pou KM, Massaro JM, Hoffmann U, Vasan RS, Maurovich- Horvat P, Larson MG, Keaney Jr JF, Meigs JB, Lipinska I, Kathiresan S, et al. Viscl and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation 2007;116:1234-1241.
7. Catalano PM, Huston L, Amini SB, Kalhan SC. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolnce and gestational diabetes mellitus. Am J Obstet Gynecol 1999;180:903-916.
8. Chen X, Scholl TO. Oxidative stress: changes in pregnancy and with gestational diabetes mellitus. Curr Diab Rep 2005;5: 282-288.
9. Paradisi G, Biaggi A, Ferrazzani S, De Carolis S, Caruso A. Abnormal carbohydrate metabolism during pregnancy: association with endothelial dysfunction. Diabetes Care 2002;25: 560-564.
10. Catalano PM, Ehrenberg HM. The short and long-term implications of maternal obesity on the mother and her offspring. Br J Obstet Gynaecol 2006;113:1126-1133.
11. Sanchez-V I, Bonet B, Viana M, Quintanar A, MartinMD, Blanco P, Donnay S, Albi M. Changes in plasma lipids and increased low-density lipoprotein susceptibility to oxidation in pregnancies complicated by gestational diabetes: consequences of obesity. Metab Clin Exp 2007;56:1527-1533.
12. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004;114:1752-1761.
13. Yamauchi T, Kamon J, Waki H, Tuchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N. The fat-derived hormone adiponectin reverses insulin-resistance associated with both lipoatrophy and obesity. Nat Med 2001;7(8):941-946.
14. Steinberg D. Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat Med 2002;8:1211-1217.
15. Fraley AE, Tsimikas S. Clinical applications of circulating oxidized low-density lipoprotein biomarkers in cardiovascular disease. Curr Opin Lipidol 2006;17:502-509.
16. Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006;440:944-948.
17. Evans JL, Maddux BA, Goldfine ID. The molecular basis for oxidative stress-induced insulin resistance. Antioxid Redox Signal 2005;7:1040-1052.
18. Ishigaki Y, Oka Y, Katagiri H. Circulating oxidized LDL: a biomarker and pathogenic factor. Curr Opin Lipidol 2009;20: 363-369.
19. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb. Vasc. Biol. 2004;24:29-33.
20. Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, Arita Y, Okamoto Y, Shimomura I, Hiraoka H, et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb. Vasc. Biol. 2003; 23:85-89.
21. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb. Vasc. Biol. 2000;20:1595-1599.
22. Li R, Wang WQ, Zhang H, Yang X, Fan Q, Christopher TA, Lopez BL, Tao L, Goldstein BJ, Gao F, et al. Adiponectin improves endothelial function in hyperlipidemic rats by reducing oxidative/nitrative stress and differential regulation of eNOS/iNOS activity. Am J Physiol Endocrinol Metab 2007;293:E1703-E1708.
23. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-83.
24. Prior SL, Gable DR, Cooper JA, Bain SC, Hurel SJ, Humphries SE, Stevens JW. Association between the adiponectin promoter rs266729 gene variant and oxidative stress in patients with diabetes mellitus. Eur Heart J 2009;30:1263-1269.
25. Hattori S, Hattori Y, Kasai K. Hypoadiponectinemia is caused by chronic blockade of nitric oxide synthesis in rats. Metabolism 2005;54:482-487.
26. Panidis D, Farmakiotis D, Rousso D, Koliakos G, Kaltsas Th, Krassas G. Decrease in adiponectin levels in women with polycystic ovary syndrome after an oral glucose tolnce test. Fertil Steril 2005;83:232-234.
27. English PJ, Coughlin SR, Hayden K, Malik IA, Wilding JP. Plasma adiponectin increases postprandially in obese but not in lean subjects. Obes Res 2003;11:839-844.
28. Van Linthout S, Foryst-Ludwig A, Spillmann F, Peng J, Feng Y, Meloni M, Van Craeyveld E, Kintscher U, Schultheiss HP, De Geest B, et al. Impact of HDL on adipose tissue metabolism and adiponectin expression. Atherosclerosis 2010;210:438-444.
29. Nakanishi S, Yamane K, Kamei N, Nojima H, Okubo M, Kohno N. A protective effect of adiponectin against oxidative stress in Japanese Americans: the association between adiponectin or leptin and urinary isoprostane. Metabolism 2005;54:194-199.